相似文献
1
Nanomedicine Technologies for Diagnosis and Treatment of Breast Cancer.
ACS Pharmacol Transl Sci. 2023 Apr 21;6(5):671-682. doi: 10.1021/acsptsci.3c00044. eCollection 2023 May 12.
2
The potential role of nanomedicine in the treatment of breast cancer to overcome the obstacles of current therapies.
Front Pharmacol. 2023 Feb 22;14:1143102. doi: 10.3389/fphar.2023.1143102. eCollection 2023.
3
Nanomedicine applications in the treatment of breast cancer: current state of the art.
Int J Nanomedicine. 2017 Aug 16;12:5879-5892. doi: 10.2147/IJN.S123437. eCollection 2017.
4
Non-coding RNAs and estrogen receptor signaling in breast cancer: Nanotechnology-based therapeutic approaches.
Pathol Res Pract. 2024 Nov;263:155568. doi: 10.1016/j.prp.2024.155568. Epub 2024 Aug 29.
5
Nanomedicine-Based Delivery Strategies for Breast Cancer Treatment and Management.
Int J Mol Sci. 2022 Mar 5;23(5):2856. doi: 10.3390/ijms23052856.
6
Recent advancement of nanomedicine-based targeted delivery for cervical cancer treatment.
Med Oncol. 2023 Nov 6;40(12):347. doi: 10.1007/s12032-023-02195-3.
7
Carbon Nanotubes in Breast Cancer Treatment: An Insight into Properties, Functionalization, and Toxicity.
Anticancer Agents Med Chem. 2023;23(14):1606-1617. doi: 10.2174/1871520623666230510094850.
8
Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
Drug Resist Updat. 2017 Mar;31:15-30. doi: 10.1016/j.drup.2017.05.002. Epub 2017 May 21.
9
The development and progress of nanomedicine for esophageal cancer diagnosis and treatment.
Semin Cancer Biol. 2022 Nov;86(Pt 2):873-885. doi: 10.1016/j.semcancer.2022.01.007. Epub 2022 Jan 21.
10
Nanomedicine in lung cancer: Current states of overcoming drug resistance and improving cancer immunotherapy.
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021 Jan;13(1):e1654. doi: 10.1002/wnan.1654. Epub 2020 Jul 22.
引用本文的文献
1
A Comprehensive Review of Current Approaches in Bladder Cancer Treatment.
ACS Pharmacol Transl Sci. 2025 Jan 6;8(2):286-307. doi: 10.1021/acsptsci.4c00663. eCollection 2025 Feb 14.
2
From Pioneering Discoveries to Innovative Therapies: A Journey Through the History and Advancements of Nanoparticles in Breast Cancer Treatment.
Breast Cancer (Dove Med Press). 2025 Jan 21;17:27-51. doi: 10.2147/BCTT.S501448. eCollection 2025.
3
Self-assembled lipid-based nanoparticles for chemotherapy against breast cancer.
Front Bioeng Biotechnol. 2024 Oct 29;12:1482637. doi: 10.3389/fbioe.2024.1482637. eCollection 2024.
4
A Cross-talk between Nanomedicines and Cardiac Complications: Comprehensive View.
Curr Pharm Des. 2025;31(10):741-752. doi: 10.2174/0113816128347223241021111914.
5
Current advance of nanotechnology in diagnosis and treatment for malignant tumors.
Signal Transduct Target Ther. 2024 Aug 12;9(1):200. doi: 10.1038/s41392-024-01889-y.
6
Tumor versus Tumor Cell Targeting in Metal-Based Nanoparticles for Cancer Theranostics.
Int J Mol Sci. 2024 May 10;25(10):5213. doi: 10.3390/ijms25105213.
7
Impact of Nanomedicine in Women's Metastatic Breast Cancer.
Small. 2024 Oct;20(41):e2301385. doi: 10.1002/smll.202301385. Epub 2023 Jun 3.
本文引用的文献
1
The protein corona from nanomedicine to environmental science.
Nat Rev Mater. 2023 Mar 24:1-17. doi: 10.1038/s41578-023-00552-2.
2
Cancer statistics, 2023.
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
3
The Issue of Reliability and Repeatability of Analytical Measurement in Industrial and Academic Nanomedicine.
ACS Nano. 2023 Jan 10;17(1):4-11. doi: 10.1021/acsnano.2c09249. Epub 2022 Dec 27.
4
Targeting the PI3K/AKT/mTOR Signaling Pathway in the Treatment of Human Diseases: Current Status, Trends, and Solutions.
J Med Chem. 2022 Dec 22;65(24):16033-16061. doi: 10.1021/acs.jmedchem.2c01070. Epub 2022 Dec 12.
5
Measurements of heterogeneity in proteomics analysis of the nanoparticle protein corona across core facilities.
Nat Commun. 2022 Nov 3;13(1):6610. doi: 10.1038/s41467-022-34438-8.
6
Breast Cancer Statistics, 2022.
CA Cancer J Clin. 2022 Nov;72(6):524-541. doi: 10.3322/caac.21754. Epub 2022 Oct 3.
7
Nanocarriers: A Reliable Tool for the Delivery of Anticancer Drugs.
Pharmaceutics. 2022 Jul 28;14(8):1566. doi: 10.3390/pharmaceutics14081566.
8
Importance of Standardizing Analytical Characterization Methodology for Improved Reliability of the Nanomedicine Literature.
Nanomicro Lett. 2022 Aug 20;14(1):172. doi: 10.1007/s40820-022-00922-5.
9
Nanomedicine-Based Delivery Strategies for Breast Cancer Treatment and Management.
Int J Mol Sci. 2022 Mar 5;23(5):2856. doi: 10.3390/ijms23052856.
10
Triple-Negative Breast Cancer: A Brief Review About Epidemiology, Risk Factors, Signaling Pathways, Treatment and Role of Artificial Intelligence.
Front Mol Biosci. 2022 Jan 25;9:836417. doi: 10.3389/fmolb.2022.836417. eCollection 2022.
Zotero 插件